The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 14, 2025

Filed:

Jan. 10, 2023
Applicants:

Evotec International Gmbh, Hamburg, DE;

Sanofi, Paris, FR;

Inventor:

Antoine Alam, Lyons, FR;

Assignees:

EVOTEC INTERNATIONAL GmbH, Hamburg, DE;

SANOFI, Paris, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2005.12); A61K 38/21 (2005.12); A61P 31/20 (2005.12); C07K 14/555 (2005.12); C07K 16/28 (2005.12); C12N 15/63 (2005.12);
U.S. Cl.
CPC ...
C07K 16/2878 (2012.12); A61P 31/20 (2017.12); C07K 14/555 (2012.12); C12N 15/63 (2012.12); C07K 2317/55 (2012.12); C07K 2317/565 (2012.12); C07K 2319/33 (2012.12);
Abstract

The present invention relates to novel interferon-associated antigen binding proteins as well as nucleic acids, vectors and vector systems encoding such interferon-associated antigen binding proteins. The present invention also relates to compositions comprising such interferon-associated antigen binding proteins, nucleic acids, vectors and vector systems. The novel interferon-associated antigen binding proteins afford beneficial improvements over the current state of the art, for example inthat they effectively disrupt viral replication and thereby reduce HBV viral load. Thus, the present invention also provides medical uses of such interferon-associated antigen binding proteins, nucleic acids, vectors, vector systems and compositions, e.g., in the treatment of hepatitis B virus (HBV) infection and/or for decreasing one or more symptoms of HBV infection in a subject. The present invention further provides host cells comprising such nucleic acids, vectors and vector systems as well as methods of making the interferon-associated antigen binding proteins according to the invention using said host cells.


Find Patent Forward Citations

Loading…